Bedtime Blood Glucose of 12.3 mmol/L (221 mg/dL) on Sliding Scale Insulin
Yes, a bedtime glucose of 12.3 mmol/L (221 mg/dL) is concerning and indicates your current sliding scale insulin regimen is inadequate—you need to transition immediately to a scheduled basal-bolus insulin regimen rather than relying on reactive sliding scale coverage alone. 1, 2
Why This Glucose Level Matters
Your bedtime glucose of 221 mg/dL significantly exceeds the recommended target of <180 mg/dL for hospitalized patients 1. This level of persistent hyperglycemia is associated with:
- Increased infection risk through impaired immune function, including decreased white blood cell mobilization and phagocytic activity 3
- Higher in-hospital mortality and complications, even in patients without pre-existing diabetes 4, 5
- Poor overall glycemic control that sliding scale insulin alone cannot adequately address 1, 2
The Critical Problem: Sliding Scale Insulin Alone is Inadequate
The American Diabetes Association explicitly states that sliding scale insulin (SSI) as the sole method of treatment is strongly discouraged in hospitalized patients. 1, 2 Here's why your current approach is failing:
- SSI treats hyperglycemia reactively after it occurs rather than preventing it, leading to dangerous glucose fluctuations 2
- SSI provides no basal insulin coverage between meals or overnight, allowing glucose to rise unchecked 2
- Randomized trials demonstrate that basal-bolus regimens provide superior glycemic control and reduce hospital complications compared to SSI alone 2
What You Need Instead: Basal-Bolus Insulin Regimen
For a patient already requiring insulin with glucose levels in the 220s mg/dL, you need scheduled basal insulin (like Lantus/glargine) plus correction insulin (like Lispro), not SSI alone. 2
Recommended Starting Regimen:
Basal Insulin Component:
- Start with 10 units of long-acting basal insulin (Lantus/glargine) once daily at the same time each day 2, 6
- Alternatively, use 0.1-0.2 units/kg body weight as your starting dose 2, 6
- This provides essential 24-hour background insulin coverage 2
Correction Insulin Component:
- Continue short-acting insulin (Lispro) before meals only as correction doses 2
- Use a simplified scale: 2 units for glucose >250 mg/dL, 4 units for glucose >350 mg/dL 2
- Never use rapid-acting insulin at bedtime due to nocturnal hypoglycemia risk 2
Titration Protocol:
Increase basal insulin aggressively based on fasting glucose patterns 2, 6:
- If fasting glucose ≥180 mg/dL: increase by 4 units every 3 days 2
- If fasting glucose 140-179 mg/dL: increase by 2 units every 3 days 2
- Target fasting glucose: 80-130 mg/dL (4.4-7.2 mmol/L) 2
Monitoring Requirements
- Check fasting glucose daily during titration to guide basal insulin adjustments 2
- Monitor for hypoglycemia, especially overnight between midnight and 6:00 AM when risk peaks 1
- If glucose falls <100 mg/dL (5.6 mmol/L), reassess the regimen 1
- If glucose <70 mg/dL (3.9 mmol/L), reduce insulin dose by 10-20% immediately 1, 2
Critical Threshold to Watch
When your basal insulin dose exceeds 0.5 units/kg/day and approaches 1.0 units/kg/day, you'll need to add mealtime (prandial) insulin rather than continuing to escalate basal insulin alone. 2 Signs you've reached this threshold include:
- Bedtime-to-morning glucose differential ≥50 mg/dL 2
- Hypoglycemia episodes 2
- High glucose variability 2
Common Pitfalls to Avoid
- Don't continue SSI as your only treatment—this unnecessarily prolongs hyperglycemia exposure and increases complication risk 1, 2
- Don't withhold basal insulin when glucose is elevated—this is a common error that worsens hyperglycemia 2
- Don't delay insulin adjustments—basal insulin can be adjusted every 3 days even while receiving correction insulin 2
- Don't ignore persistent hyperglycemia—glucose levels consistently >180 mg/dL require immediate regimen changes 1
Special Considerations
If you have poor oral intake or are NPO (nothing by mouth), a basal-plus-correction regimen is still preferred over SSI alone, with correction doses given every 4-6 hours 1, 2. For patients on high-dose home insulin (≥0.6 units/kg/day), reduce the total daily dose by 20% during hospitalization to prevent hypoglycemia 7.